Airbus Closes In On 770 Airplane Delivery Target
Airbus saw a strong increase in deliveries, increasing its chances to reach its delivery target for the full year. Read why ...
Serve Robotics: Dirt Cheap AI Stock With Huge Upside
Serve Robotics partners with Uber to revolutionize last-mile delivery with autonomous robots, leading in sustainability and ...
An Investor's Guide to the Artificial Intelligence (AI) Value Chain
The artificial intelligence (AI) revolution extends far beyond chatbots and automation to fundamentally restructure ...
Why Are Nvidia and Uber Backing This Tiny $400 Million Artificial Intelligence (AI) Company?
Nvidia ( NVDA -1.81%) is the leading supplier of high-end graphics processing units (GPUs) for data centers, where they are ...
MosquitoMate receives first Vector Expedited Review Voucher (VERV) from the US Environmental Protection Agency
The US Environmental Protection Agency (EPA) has just announced MosquitoMate as its first awardee in a new effort to fight ...
Postal Service EV Order Is in Jeopardy, Report Says. This Stock Is Down.
President-elect Trump might stop the USPS from buying EVs. It’s another reminder he isn’t a big fan of battery-powered cars.
Share Market Highlights: Sensex, Nifty surge 1% as IT stocks rally on positive US economic outlook
Indian shares rose on Thursday, boosted by a significant jump in U.S.-focused IT stocks amid optimism surrounding the ...
Genetic Immunity (GI) Leverages VectorBuilder Partnership to Power Phase 3 HIV Vaccine Trials
Genetic Immunity, a leader in plasmid DNA-based immunotherapies, and VectorBuilder, a global specialist in gene delivery solutions, announced a strategic partnership to advance Genetic Immunity's ...
Business Insider8d
AAVantgarde announces oral presentation of LUCE-1 clinical study at FLORetina 2024 annual meeting
MILAN, Dec. 03, 2024 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage, Italian-based international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector ...
Business Insider9d
AAVantgarde Bio Announces FDA Orphan Drug Designation for AAVB-081 for the Treatment of Usher Syndrome Type 1B Retinitis Pigmentosa
MILAN, Dec. 02, 2024 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage, Italian-based international biotechnology company with two proprietary Adeno-Associated Viral (AAV) vector ...